Recent Posts

U.S. Supreme Court Makes It Easier To Sue Businesses
Posted on 23 Mar 2011 by LexisNexis Litigation Resource Community Staff

WASHINGTON, D.C. - (AP) The Supreme Court made it easier to haul businesses into court on Tuesday, ruling that investors can sue them for purposefully withholding damaging information about a product and that employees can sue them for retaliation without... Read More

High Court: Investors Properly Pleaded Materiality In Securities Class Action Suit
Posted on 23 Mar 2011 by Timothy Raub

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on March 22 unanimously affirmed that shareholders of a drug maker properly showed that the drug maker violated federal securities law by failing to disclose that one of its products caused adverse... Read More

James M. Wilson Jr. On Securities Class Actions - Analysis Of The Supreme Court's Decision In Erica P. John Fund, Inc. v. Halliburton Co.
Posted on 27 Jun 2011 by James M. Wilson, Jr.

Excerpt: Introduction: On June 6, 2011, the Supreme Court unanimously rejected the Fifth Circuit Court of Appeal's requirement that plaintiffs in securities class actions prove "loss causation" at the class certification stage of the case... Read More

High Court Rejects 'Statistical Significance' Requirement For Securities Lawsuit Materiality
Posted on 24 Mar 2011 by Kevin M. LaCroix

In a unanimous March 22, 2011 opinion by Justice Sonia Sotomayor , the U.S. Supreme Court rejected the argument of Matrixx Initiatives that adverse product reports must be "statistically significant" in order for a manufacturer to have an obligation... Read More

Zicam Maker Settles 2,100 Smell/Taste Injury Claims For $15.5M
Posted on 14 Dec 2010 by Tom Moylan

SCOTTSDALE, Ariz. -- (Mealey's) Zicam maker Matrixx Initiatives Inc. on Dec. 14 said it has agreed to settle about 2,100 claims by people who claim to have lost their sense of smell or taste from the company's zinc-based nasal cold remedy gel... Read More

Drug Maker To Pay $4.5 Million To Settle Claims In Securities Class Action Lawsuit
Posted on 30 Jul 2012 by Timothy Raub

PHOENIX - (Mealey's) Matrixx Initiatives Inc. will pay $4.5 million to settle claims with shareholders that it violated federal securities law by concealing side effects of a cold medication it developed and marketed, according to documents filed... Read More

Massachusetts Man Files Product Liability Suit Over Zicam Gel
Posted on 2 Jul 2010 by LexisNexis Litigation Resource Community Staff

BOSTON - Burns & Levinson LLP on June 30 announced that a Massachusetts man filed a class action lawsuit in the U.S. District Court for the District of Massachusetts, claiming injuries including loss of sense of smell and diminished sense of taste... Read More

Chesley Files Federal Zicam Lawsuits
Posted on 11 Mar 2010 by LexisNexis Litigation Resource Community Staff

CINCINNATI — Stanley M. Chesley from the Cincinnati-based law firm of Waite, Schneider, Bayless & Chesley Co. L.P.A. on March 3 filed federal lawsuits in Ohio and Kentucky against Matrixx Initiatives, the manufacturer of Zicam, on behalf... Read More